Digital Diabetes Management Market Size At Around US$ 90 Bn In 2030

The digital diabetes management market would grow at a CAGR of 18.85% over the predicted time frame. The market is expected to increase in value from US$ 22.6 Bn in 2022 to US$ 90 Bn in 2030.

The on digital diabetes management Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1783

Report Coverage	Details
Market Size by 2030	USD 90 Billion
Growth Rate from 2022 to 2030	CAGR of 18.85%
Largest Market	North America
Fastest Growing Region	Asia Pacific
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	Product, Device Type, Patient Type, App, End-Use, Geography

A recent report provides crucial insights along with application based and forecast information in the Global Digital diabetes management Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Digital diabetes management market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Digital diabetes management market are included as given below:

Digital diabetes management Market Key Players

• Bayer AG
• Medtronic
• Roche Diagnostics
• Dexcom Inc. LifeScan Inc.
• AgaMatrix
• One Drop
• Abbott Laboratories
• Ascensia Diabetes Care
• ARKRAY Inc
• ACON Laboratories
• Insulet Corporation
• B. Braun Melsungen AG
• Tandem Diabetes Care
• Dottli
• Ypsomed Holding AG
• Becton Dickinson and Company
• Glooko Inc.
• DarioHealth
• Care innovations

Market Segments

 By Product

• Devices
• Smart Glucose Meters
• Continuous Glucose Monitoring (CGM) Systems
• Smart Insulin Pens
• Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches
• Application
• Diabetes & Blood Glucose Tracking Apps
• Obesity & Diet Management Apps
• Data Management Software & Platforms
• Services
• Apps
• Software

By Device Type

• Handheld Devices
• Wearable Devices

By Patient Type

• Type 1
• Type 2

By App

• Digital Diabetes Management Apps
• Weight & Diet Management Apps

By End-Use

• Hospitals
• Home Settings
• Diagnostic Centers & Clinics

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa

Report Objectives

• To define, describe, and forecast the global digital diabetes management market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the digital diabetes management market

Table of Content

 Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Digital Diabetes Management Market 

5.1. COVID-19 Landscape: Digital Diabetes Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Digital Diabetes Management Market, By Product

8.1. Digital Diabetes Management Market, by Product, 2022-2030

8.1.1. Devices

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Application

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Data Management Software & Platforms

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Services

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Digital Diabetes Management Market, By Device Type

9.1. Digital Diabetes Management Market, by Device Type, 2022-2030

9.1.1. Handheld Devices

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Wearable Devices

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Digital Diabetes Management Market, By Patient Type 

10.1. Digital Diabetes Management Market, by Patient Type, 2022-2030

10.1.1. Type 1

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Type 2

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Digital Diabetes Management Market, By App

11.1. Digital Diabetes Management Market, by App, 2022-2030

11.1.1. Digital Diabetes Management Apps

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Weight & Diet Management Apps

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Digital Diabetes Management Market, By End-Use

12.1. Digital Diabetes Management Market, by End-Use, 2022-2030

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Home Settings

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Diagnostic Centers& Clinics

12.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Digital Diabetes Management Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.1.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.1.4. Market Revenue and Forecast, by App (2017-2030)

13.1.5. Market Revenue and Forecast, by End-Use (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.1.6.4. Market Revenue and Forecast, by App (2017-2030)

13.1.7. Market Revenue and Forecast, by End-Use (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.1.8.4. Market Revenue and Forecast, by App (2017-2030)

13.1.8.5. Market Revenue and Forecast, by End-Use (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.2.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.2.4. Market Revenue and Forecast, by App (2017-2030) 

13.2.5. Market Revenue and Forecast, by End-Use (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.2.7. Market Revenue and Forecast, by App (2017-2030) 

13.2.8. Market Revenue and Forecast, by End-Use (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.2.10. Market Revenue and Forecast, by App (2017-2030)

13.2.11. Market Revenue and Forecast, by End-Use (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.2.12.4. Market Revenue and Forecast, by App (2017-2030)

13.2.13. Market Revenue and Forecast, by End-Use (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.2.14.4. Market Revenue and Forecast, by App (2017-2030)

13.2.15. Market Revenue and Forecast, by End-Use (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.3.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.3.4. Market Revenue and Forecast, by App (2017-2030)

13.3.5. Market Revenue and Forecast, by End-Use (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.3.6.4. Market Revenue and Forecast, by App (2017-2030)

13.3.7. Market Revenue and Forecast, by End-Use (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.3.8.4. Market Revenue and Forecast, by App (2017-2030)

13.3.9. Market Revenue and Forecast, by End-Use (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.3.10.4. Market Revenue and Forecast, by App (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End-Use (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.3.11.4. Market Revenue and Forecast, by App (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End-Use (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.4.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.4.4. Market Revenue and Forecast, by App (2017-2030)

13.4.5. Market Revenue and Forecast, by End-Use (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.4.6.4. Market Revenue and Forecast, by App (2017-2030)

13.4.7. Market Revenue and Forecast, by End-Use (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.4.8.4. Market Revenue and Forecast, by App (2017-2030)

13.4.9. Market Revenue and Forecast, by End-Use (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.4.10.4. Market Revenue and Forecast, by App (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End-Use (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.4.11.4. Market Revenue and Forecast, by App (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End-Use (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.5.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.5.4. Market Revenue and Forecast, by App (2017-2030)

13.5.5. Market Revenue and Forecast, by End-Use (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.5.6.4. Market Revenue and Forecast, by App (2017-2030)

13.5.7. Market Revenue and Forecast, by End-Use (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Device Type (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Patient Type (2017-2030)

13.5.8.4. Market Revenue and Forecast, by App (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End-Use (2017-2030)

Chapter 14. Company Profiles

14.1. Bayer AG

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Medtronic

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Roche Diagnostics

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Dexcom Inc. LifeScan Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. AgaMatrix

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. One Drop

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Abbott Laboratories

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Ascensia Diabetes Care

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. ARKRAY Inc

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. ACON Laboratories

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com